As of Sep 20
| +1.29 / +0.66%|
The 17 analysts offering 12-month price forecasts for Amgen Inc have a median target of 218.00, with a high estimate of 243.00 and a low estimate of 173.00. The median estimate represents a +10.69% increase from the last price of 196.94.
The current consensus among 22 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.